Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:O15067 (
FGAM synthetase
)
19
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phosphoribosylformylglycinamidine synthase
(
PFAS
) is an essential enzyme in de novo synthesis of purine. Previously,
PFAS
has been reported to modulate RIG-I activation during viral infection via deamidation. In this study, we sought to identify potential substrates that
PFAS
can deamidate. Flag-
PFAS
was transfected into
HEK
-293T cells and
PFAS
associated proteins were purified with anti-Flag M2 magnetic beads.
PFAS
associated proteins were identified using mass spectrometry and were analyzed using bioinformatics tools including KEGG pathway analysis, gene ontology annotation, and protein interaction network analysis. A total of 441 proteins is suggested to potentially interact with
PFAS
. Of this number, 12 were previously identified and 429 are newly identified. The interactions of
PFAS
with CAD, CCT2, PRDX1, and PHGDH were confirmed by co-immunoprecipitation and western blotting. This study is first to report the interaction of
PFAS
with several proteins which play physiological roles in tumor development including CAD, CCT2, PRDX1, and PHGDH. Furthermore, we show here that
PFAS
is able to deamidate PHGDH, and induce other posttranslational modification into CAD, CCT2 and PRDX1. The present data provide insight on the biological function of
PFAS
. Further study to explore the role of these protein interactions in tumorigenesis and other diseases is recommended.
...
PMID:Protein interactome of the deamidase phosphoribosylformylglycinamidine synthetase (PFAS) by LC-MS/MS. 3098 22